 |
PDBsum entry 3hs6
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
3hs6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural basis of fatty acid substrate binding to cyclooxygenase-2.
|
 |
|
Authors
|
 |
A.J.Vecchio,
D.M.Simmons,
M.G.Malkowski.
|
 |
|
Ref.
|
 |
J Biol Chem, 2010,
285,
22152-22163.
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
The cyclooxygenases (COX-1 and COX-2) are membrane-associated, heme-containing
homodimers that generate PGH2 from arachidonic acid (AA). While AA is the
preferred substrate, other fatty acids are oxygenated by these enzymes with
varying efficiencies. We determined the crystal structures of AA,
eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) bound to
Co(3+)-protoporphyrin IX reconstituted murine COX-2 to 2.1A, 2.4A, and 2.65A,
respectively. AA, EPA, and DHA bind in different conformations in each monomer
constituting the homodimer in their respective structures such that one monomer
exhibits non-productive binding and the other productive binding of the
substrate in the cyclooxygenase channel. The interactions identified between
protein and substrate when bound to COX-1 are conserved in our COX-2 structures,
with the only notable difference being the lack of interaction of the
carboxylate of AA and EPA with the side chain of Arg-120. Leu-531 exhibits a
different side chain conformation when the non-productive and productive binding
modes of AA are compared. Unlike COX-1, mutating this residue to Ala, Phe, Pro,
or Thr did not result in a significant loss of activity or substrate binding
affinity. Determination of the L531F:AA crystal structure resulted in AA binding
in the same global conformation in each monomer. We speculate that the mobility
of the Leu-531 side chain increases the volume available at the opening of the
cyclooxygenase channel and contributes to the observed ability of COX-2 to
oxygenate a broad spectrum of fatty acid and fatty ester substrates.
|
 |
|
|
|
|
 |